Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Cranford L. Scott"'
Clinical Outcomes by Race in Hypertensive Patients with and without the Metabolic Syndrome in ALLHAT
Autor:
Jackson T, Wright, Sonja, Harris-Haywood, Sara, Pressel, Joshua, Barzilay, Charles, Baimbridge, Charles J, Bareis, Jan N, Basile, Henry R, Black, Richard, Dart, Alok K, Gupta, Bruce P, Hamilton, Paula T, Einhorn, L Julian, Haywood, Syed Z A, Jafri, Gail T, Louis, Paul K, Whelton, Cranford L, Scott, Debra L, Simmons, Carol, Stanford, Barry R, Davis
Antihypertensive drugs with favorable metabolic effects are advocated for first-line therapy in hypertensive patients with metabolic/cardiometabolic syndrome (MetS). We compared outcomes by race in hypertensive individuals with and without MetS treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f9f118759252bd310cf6a585a2fa9eac
https://europepmc.org/articles/PMC2805022/
https://europepmc.org/articles/PMC2805022/
Autor:
Cranford L. Scott
Publikováno v:
The American journal of cardiology. 92(1A)
The term metabolic syndrome refers to a virulent and lethal group of atherosclerotic risk factors, including dyslipidemia, insulin resistance, obesity, and hypertension. This syndrome affects some 47 million people in the United States, placing them
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70b258353378a57cb4e464c48f1c8be3
https://pubmed.ncbi.nlm.nih.gov/12867253
https://pubmed.ncbi.nlm.nih.gov/12867253
Autor:
Syed Z. A. Jafri, Bruce P. Hamilton, Charles J. Bareis, Sara L. Pressel, Barry R. Davis, Carol Stanford, Jan Basile, Sonja Harris-Haywood, Paul K. Whelton, Joshua I. Barzilay, Richard A. Dart, L. Julian Haywood, Paula T. Einhorn, Gail T. Louis, Debra L. Simmons, Cranford L. Scott, Henry R. Black, Charles Baimbridge, Alok Gupta, Jackson T. Wright
Publikováno v:
Archives of Internal Medicine. 168:207
Background: Antihypertensive drugs with favorable metabolic effects are advocated for first-line therapy in hypertensivepatientswithmetabolic/cardiometabolicsyndrome (MetS). We compared outcomes by race in hypertensiveindividualswithandwithoutMetStre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51ecc71eeb68fe0e65e09797e95f6552
https://doi.org/10.1001/archinternmed.2007.66
https://doi.org/10.1001/archinternmed.2007.66
Publikováno v:
The Journal of clinical endocrinology and metabolism. 40(2)
One gram of l-dopa was administered orally to 12 male control subjects and induced an increase of growth hormone (GH) secretion. The l-dopa-induced GH response was inhibited by an intravenous infusion of pyridoxine, but pyridoxinedid not inhibit the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::454ad639096e58553371dbdda9506815
https://pubmed.ncbi.nlm.nih.gov/1117978
https://pubmed.ncbi.nlm.nih.gov/1117978
Publikováno v:
The Journal of clinical endocrinology and metabolism. 37(5)
We have reported inhibitory effects of hyperglycemia upon l-dopa-induced growth hormone (GH) stimulation in normal subjects and in hyperglycemic patients due to diabetes mellitus. Ten normal subjects whose GH rose greater than 10 ng/ml following 1.0
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34b2cb5fbed61eacf53697750d8fc4d2
https://pubmed.ncbi.nlm.nih.gov/4749441
https://pubmed.ncbi.nlm.nih.gov/4749441